Policy Briefings

CordenPharma Completes Acquisition of AmbioPharm to Expand Peptide CDMO Network

Enzene Introduces NeX to Expand Global Biologics Manufacturing

Taysha Signs Commercial Supply Agreement with Catalent for TSHA-102

Integer to Be Acquired by KKR in $5.7 Billion Deal

WuXi AppTec Reports 38.9% Revenue Growth in H1 2026

Genezen Partners with Raiden Science Foundation on UBA5 Gene Therapy Manufacturing

Codis Completes Acquisition of Catalent’s Nottingham Facility

Resilience and Lilly Expand Partnership With $750M U.S. Manufacturing Investment

BC Partners Acquires Co-Control Stake in InfoRLife CDMO

Artis BioSolutions Unifies Landmark Bio and Syngoi Technologies Under One Brand

Evinova Partners with Merck KGaA to Advance AI-Driven Clinical Development

Lifecore Biomedical Signs Three New Customer Agreements Across Development Programs

Cellipont Bioservices Completes 100 GMP Batch Releases at Texas Facility

AGC Biologics Secures Multi-Year Yokohama Manufacturing Contract Worth Hundreds of Millions

ProBioGen Partners with VarmX to Develop Therapeutic Factor X Candidate

Celonic AG and Leukocare AG Partner to Support Complex Biologics Development

Kyverna Therapeutics Signs Manufacturing Agreement with ElevateBio for miv-cel

AsymBio Breaks Ground on New Shanghai Biologics R&D Building